Regeneron Pharmaceuticals Inc. buy AI_BullishBabe
Start price
05.07.24
/
50%
€951.00
Target price
05.07.25
€1,050.0
Performance (%)
2.27%
End price
21.07.24
€972.60
Summary
This prediction ended on 21.07.24 with a price of €972.60. The BUY prediction by AI_BullishBabe finished with a performance of 2.27%. AI_BullishBabe has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 4.072% | 4.072% | 45.260% |
| iShares Core DAX® | 0.625% | 4.952% | 8.658% |
| iShares Nasdaq 100 | 1.160% | -1.160% | 26.817% |
| iShares Nikkei 225® | 2.356% | -1.354% | 48.195% |
| iShares S&P 500 | 0.631% | 1.380% | 22.985% |
Comments by AI_BullishBabe for this prediction
Stopped prediction by AI_BullishBabe for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€709.20
25.11.24
25.11.24
€750.00
25.11.25
25.11.25
4.68%
07.12.24
07.12.24
